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                                      INTRODUCTION                 
The urge for Motherhood is unique.  The term ‘Safe- Motherhood’ is nowadays a 
slogan, not only in relation to mother but also in relation to fetus.
Uterine Bleed in early pregnancy represents a definite threat to developing embryo 
and constitutes a source of Anxiety to both the patient and the clinician.
Vaginal  Bleed during first  trimester  has been estimated to occur  in 16% of all 
pregnant women.  A spectrum of causes for first trimester Bleed has been identified 
ranging from Threatened Abortion, Complete Abortion.  Incomplete Abortion, Missed 
Abortion, Gestational Trophoblastic disease, Ectopic Gestation.
In  first  trimester  pregnancies  Complicated  by  bleed  less  than  50%  progress 
normally beyond 20 weeks of Gestation, 10-15% will be ectopic pregnancy, 0.2% will 
be  a  hydatidiform mole  and  30%  miscarry  Approximately  5%  of  Women  elect  to 
terminate the pregnancy.
About 15% of Pregnancies are complicated by Threatened miscarriage.
Threatened Abortion is a clinically descriptive term that applies to women who are 
at less than 20 weeks Gestation with a viable pregnancy and have Vaginal spotting or 
bleeding, a closed Cervical os and possibly mild uterine cramping.
It   has  been  shown  to  be  associated  with  an  increased  risk  of  poor  obstetric 
outcomes  such  as  preterm  labour,  Low  birth  weight  and  premature  rupture  of 
Membranes.
Moreover when pregnant - women have bleeding, it may cause stress and anxiety 
for the Mother to be about the outcome of pregnancy.  This can be a difficult time for 
women because of uncertainty of outcome, lack of preventive measures and emotional 
significance of early pregnancy loss.
Although few studies have evaluate outcomes other than viability at term. Most 
agree that adverse pregnancy outcome is associated with first trimester vaginal Bleed. 
The  outcome of  ongoing pregnancies after  first  firmest  bleeding  is  of  relevance to 
women  and  obstetricians  for  planning  antenatal  care  and  clinical  interventions  in 
pregnancy.The Prognosis of threatened Abortion is very unpredictable whatever method 
treatment is employed either in hospital or at  home. Threatened Abortion is such an 
event during pregnancy which needs meticulous attention to  fulfil the Purpose.Since the 
knowledge of increased risks associated with first trimester Bleed may facilitate decision 
making  regarding  management  and  decisions  regarding  mode,  place  and  timing  of 
delivery which will inevitably improve neonatal outcome, the purpose of this study is to 
evaluate the outcome of early pregnancy with a viable singleton fetus that has been 
complicated by Bleed.
AIM AND OBJECTIVE
AIM OF STUDY
To assess the Pregnancy outcome in women with Threatened miscarriage in First 
Trimester.
OBJECTIVE
To compare the pregnancy outcome in women with or without threatened first 
trimester bleed out of the hospital attendance and domiciliary management.
REVIEW OF LITERATURE
Threatened  Miscarriage  is  a  common complication  of  pregnancy  occurring  in 
15-20% of ongoing pregnancies. When pregnant  women have Bleed, it may cause stress 
and anxiety for the mother to be about the outcome of pregnancy.  So it is necessary to 
be diagnosed and Managed to prevent maternal or fetal Morbidities and Mortalities.
The clinical diagnosis of threatened abortion is presumed when a Bloody vaginal 
discharge  or  bleeding  appears  through  a  closed  cervical  os  during  the  first  half  of 
pregnancy.   Occuring  commonly  Vaginal  spotting  or  heavier  bleeding  during  early 
gestation may persist for days or weeks and may affect one out of four or five pregnant 
women.  (Over all, approximately half of these pregnancies will abort, although the risk 
is  substantially  lower  if  fetal  cardiac  activity  can  be  documented  (Tongston  and 
Colleagues 1995) The Scientific  literature  regarding threatened abortion is  relatively 
limited on the subject of outcomes and viability at term.  Many studies suggest that first 
trimester Vaginal Bleed  is associated with a worse outcome.  However there have been 
few studies that evaluated the outcomes other than viability at term after documentation 
of a living embryo.
Even without abortion, these features are at increased risk for preterm delivery, 
low birth weight and prenatal death (Batzofin, 1984) hinderburk, 1980, Weiss, 2004 and 
their  colleagues)  Importantly  the  risk  of  a  malformed  infant  does  not  appear  to  be 
increased.
Batzofin  JH  (1984) reported  that  threatened  miscarriage  doubled  the  risk  of 
delivery before 37 weeks.
Hertz JB. Heisenberg (1985) reported that Retention of placenta was associated 
with threatened miscarriage and the rate of  Manual Removal was 14%.  They postulated 
that adhesive scarring between the uterine wall and the placenta at the site of bleeding 
might be responsible for the increased incidence of retention of placenta in women with 
threatened miscarriage.
Williams MA, Mittendorf R., Liebermon E, Monson RR (1991) found a 2.5 fold 
increase in the risk of neonatal death in women with threatened miscarriage.
Das AG, Gopalan S, Dhaliwal LK (1996) reported and increased risk for a low 
lying placenta among women with threatened miscarriage but found no difference in 
placental location compared with control subjects by 36 weeks of Gestation.
Weiss JL, Malone FD 2004 found a similar association that was not statistically 
significant.
Mulik V, Bethel J, Bhalk 2004 found a significantly higher risk of placenta previa 
at 37 weeks in women who experienced a first trimester vaginal Bleed.
P. Bowe and H. Murphy (1987) reported that half  these pregnancies will continue 
though numbers will be influenced by individual admission policy.  The earlier the bleed 
the greater the risk of loss but this is only 9.3% if the fetal  heart  can be shown on 
ultrasonography.   Comparative  studies  showed  that  should  pregnancy  continue  to 
viability there is a higher incidence of preterm births, small for gestation age babies, 
retained placenta and prenatal deaths.
Weiss L, Fergal D. Malone 2003 reported  that patients with vaginal bleeding, 
light or heavy were more likely to experience a spontaneous loss before 24 weeks of 
Gestation and caesarean delivery.
John  vidaver,  Robert  H.  Ball,  Christine  H  2003 reported  that  Light  bleeding 
subjects  were  more  likely  to  have  preeclampsia,  preterm  delivery  and  placental 
abruption.   Heavy  vaginal  bleeding  subjects  were  more  likely  to  have  intrauterine 
growth  restriction,  preterm  delivery,  preterm  premature  rupture  of  membranes  and 
placental abruption.
Patients  with  symptoms  of  a  threatened  abortion  and  living  embryo  that  was 
documented after  10 weeks of  gestation are  extremely  likely to  reach viability.  The 
likelihood of maintaining a viable pregnancy was 98% through 24 weeks of gestation. 
These confirm the works of  Farrell and owen P (1996), Uer Pairojkit B (2001) and 
Williams MA (1991).
Weiss JL, Malone FD, Vidaver J (2004) reported that first trimester vaginal bleed 
may indicate underlying placental dysfunction which may manifest on late pregnancy by 
a variety of adverse outcomes that have also been related to placental dysfunction.
Verma (1993) reported that pregnancy  induced hypertension was significantly 
more common in subjects without vaginal bleed.
Both  Batzofin and Williams reported that patients with bleeding had double the 
risk of preterm delivery compared with patients without bleed.
The study of Iams JD 2003 was limited to first trimester bleed.  Batzofin included 
patients with bleeding upto 20 weeks.  Strobino Band Pantel Silverman J (1989) failed 
to show an association between preterm delivery before 36 weeks of Gestation with light 
vaginal bleed in the first trimester.
Haddow JE, knight GJ, KlozaEM (1986) reported an increased risk for low birth 
weight (<2500g) in pregnancy that was complicated by vaginal bleed.  This risk was 
increased if the maternal serum Alpha Fetoprotein level was elevated.
Weiss  L,  Vidaver  John,  Christine  H.  Comstock  2003 suggested  an  association 
between threatened abortion and PROM.  Although the cause is unclear,  The disruption 
of  chorionic  amniotic  plane  by  adjacent  hemorrhage  make  the  membranes  more 
susceptible to rupture was the hypothesis.
Alternatively, the prolonged presence of blood may act as nidus for intrauterine 
infection.   Persistent  or  recurrent  placental  hemorrhage  could  also  stimulate  uterine 
contractions that result in cervical change with eventual rupture of membranes.
Placenta previa is a common cause of obstetric vaginal bleed.  It is possible that 
first trimester bleeding could be a reflection of placenta previa in some patients.  Das 
AG, Gopalan S (1996) observed a higher rate of placenta previa among patients with 
heavy vaginal bleed during the first trimester.
M. Khanam, Nahid Yusuf, Fatema Ashraf (2005) reported that most of the cases 
of threatened Abortion were between 20-30 years age group. 71% were multigravida, 
80% were illiterate and low socio economic condition uneventfully and discharged by 
giving conservative Management.  They concluded that first trimester Vaginal bleed is 
an independent risk factor for adverse obstetric  outcome that is directly proportional to 
the amount of Bleeding.
Jemma Johns  and Eric  Jauniaux (2006)  reported  that  women presenting  with 
threatened miscarriage were more likely to deliver prematurely 5.6% and this was most 
likely to be between 34 and 37 weeks.  They were also more likely to have preterm 
prelabor rupture of membranes.
Overall there was no difference in mean birth weight and in the incidence of other 
obstetric complications.  Women in threatened miscarriage group were more likely to 
deliver neonates between 1.501 g and 2000g.
They concluded that women with threatened miscarriage in the first trimester are 
at  increased  risk  of  premature  delivery  and  this  risk  factor  should  be  taken  into 
consideration  when  deciding  upon  antenatal  surveillance  and  management  of  their 
pregnancies.
Several  studies  have reported an association  between first  trimester  bleed  and 
abnormal pregnancy outcome including preterm deliveries ; fetal growth restriction and 
low birth weight but the majority of these reports are retrospective.
The largest  study was conducted by  Weiss JL (2004) and concluded that  first 
trimester bleeding was an independent risk factor for adverse obstetric outcome. The 
Spontaneous pregnancy loss rates before 24 weeks were extremely low.
Jemma  Johns  and  Eric  Jauniaux  (2006)  suggest  that  bleeding  between  the 
chorionic  membrance  and  the  uterine  wall  can  result  in  a  spectrum  of  effects  on 
pregnancy development and outcome.  At one end, direct pressure and disruption of the 
placental bed results in miscarriage.  At the other end of the spectrum is PPROM, Where 
there  is  minimal  or  no  disruption  to  uteroplacental  development  but  a  chronic 
inflammatory reaction within the dedicua and placental membranes, with weakening and 
eventual rupture of the membranes.
Yank J, Savitz DA, Dole N (2005) found a correlation between passive smoking 
and second trimester bleeding.  This finding was supported by Mulik V (2005).
Wijesiriwardana A, Bhattacharya S, Shetty A (2006) reported that women with 
threatened miscarriage were more likely to have antepartum hemorrhage of unknown 
origin  Elective  Cesarean  and  manual  removal  of  placenta  were  performed  more 
frequently  in  these  women  who  also  had  a  higher  risk  of  preterm  delivery  and 
malpresentation.   They  concluded  that  pregnancies  complicated  by  threatened 
miscarriage are at a slightly higher risk obstetric complications and interventions.
Duff GB (1975) assessed cases of threatened abortion by means of sonar, urinary 
estrogen,  Pregnanediol  and  human  chorionic  gonadotrophin  assays  and  clinical 
examination.  Assay of estrogen excretion was the most accurate 85% in predicting the 
ultimate outcome of pregnancy but did not give as much information as sonar which 
gave an accurate prognosis in 84% cases. Assay of urinary pregnanediol excretion gave 
an accurate indication of outcome in 74% of cases and 24 hour urinary HCG in 70% of 
cases.
Garoff L, Seppnil M (1975) found that abnormally, low human placental lactogen 
(HPL)  or  high  alpha  fetoprotein  (AFP)  levels  in  maternal  serum  are  unfavourable 
prognostic signs in women with threatened abortion but normal levels cannot be used to 
discriminate between viable and nonviable pregnancies.  HPL and AFP levels provide 
complementary information as to the fetal outcome in threatened abortion.
Mark  Deutchman;  Amy  Tanner  Tubcy;  David  K  Turok  (2009) suggest  that  a 
normal  pregnancy  should  exhibit  a  gestational  sac  by  Transvaginal  ultrasonography 
when beta HCG levels are 1500 – 2000 mIU / ml.  When the gestational sac is greater 
then 10 mm diameter a yolk sac must be present.  A live embryo must exhibit cardiac 
activity when the crown rump length is greater then 5 mm.  The absence of any normal 
discriminatory findings is Consistent with early pregnancy failure. 
Mbugua Gitau G, Liversedge H, Goffey D (2009) Suggested that Age over 35 
years  was  significantly  associated  with  reduced  live-birth  and  increased  miscarriage 
rates. Women over 35 years of age had higher cesarean section and pregnancy loss rates 
than  the  younger  women.   The  combination  of  bleeding  in  early  pregnancy  and 
advanced age increase risk of pregnancy loss even after ultrasound has confirmed FH 
pulsation.
Eskild A, Vatten LJ (2009) suggested that factors associated with preeclampsia are 
inverse proportional to vaginal bleeding early in pregnancy, but positively associated 
with excess bleeding after delivery.
Aziz  S,  Cho  RC,  Bater  DB  (2008) concluded  that  In  pregnant  with  Vaginal 
bleeding, embryos of 5 mm and smaller without a heartbeat all resulted in pregnancy 
failure.
Sony YL, Zhu LP (2007) concluded that the effect of Zhixue Baotai deco ction is 
superior to progesterone in treating women of early first trimester bleed.
Johns  J,  Muttukrishna  S,  Lygnos  M (2007) suggested  that  placental  hormone 
concentrations  (Inhibin  A,  Action  A,  Human  Chorionic  Gonoadotrophin,  Pregnancy 
associated  plasma  protein  A  and  follistatin  could  be  useful  in  predicting  adverse 
pregnancy outcome in Women presenting with threatened miscarriage.  Inhibin A was 
best at predicting the likelihood of subsequent miscarriage.
Mezzesimi A, Florio P, Reis FM (2006) concluded  that the detection of anti beta – 
2  glycoprotein 1 antibodies is  associated with a  increased risk of  pregnancy loss  in 
women with threatened abortion in the first trimester.
Yin A, Ng EH, Zhang X (2007) found the correction of matermal plasma total cell-
free DNA and fetal DNA levels with short term outcome of first trimester vaginal Bleed.
They  concluded  that  matermal  plasma  fetal  and  total  DNA  Concentration 
increased throughout the first trimester . Significantly high levels of fetal and total DNA 
were found in those who miscarried.
Poulose  T,  Richardson  R,  Ewings  P  (2006) showed  the  probability  of  early 
pregnancy loss in women with vaginal bleed and a singleton live fetus at ultrasound 
scan.
The overall sponteneous miscarriage rate in the study was 11.1% almost 90% of 
pregnancies continued to viability. Women with moderate or heavy bleeding had more 
than twice the rate of miscarriage compared with those with light bleed.
A total of 14% of women  had an intrauterine hematoma and those were 2.6 times 
more likely to miscarry than those without.
Leite J, Ross P, Rossi Ac (2006) found that very large hematomas were associated 
with adverse outcome in 46% of the pregnancies.  When the hematoma was diagnosed at 
an early gestational age, the outcomes were worse.
De sutter P, Bontirick J (2006) found that first trimester bleeding in an ongoing 
singleton pregnancy following ART increases the risk for pregnancy complications.
Omar MH, Mashita MK, Lim PS (2005) Concluded that Corpus luteal support 
with  dydrogesterone  has  been shown to reduce  the incidence  of  pregnancy loss  in 
threatened abortion during the first trimester in women without a history of recurrent 
abortion.
Basama  FM,  Crosofil  F  (2004) found  that  parity,  previous  miscarriage,  the 
amount and number of episodes of vaginal bleed seem to have no influence in the rate of 
miscarriage.  Bleed in the first trimester carries a higher rate of miscarriage (15%) and 
the bleed before 6 weeks of gestation has the highest rate of miscarriage (29%).
Harville EW, Wilcox AJ, Baird DD (2003) found that very early bleed in clinical 
pregnancies is generally light and not likely to be mistaken for LMP. Thus early bleed is 
unlikely to contribute to errors in LMP based gestational age. Nearly all women with 
bleed went on to have successful pregnancies.
Johns J, Hyett J, Jauniaux E (2003) studied the obstetric outcome after threatened 
miscarriage with and without a hematoma on ultrasound.
They concluded that threatened miscarriage in the first trimester is associated with 
an increased incidence of adverse pregnancy outcome, independently of the presence of 
an  intrauterine  hematoma.   Higher  MSAFP (Maternal  Serum Alpha  Fetoprotein)  in 
threatened  miscarriage  suggests  a  direct  placental  injury  even  in  the  absence  of 
hematoma.
After sonography of pregnancies with first trimester bleed and a small intrauterine 
gestational sac without a demonstrable embryo Falco P, Zagonari S, Gabrielli S (2003) 
found that in cases with threatened abortion demonstration by Transvaginal sonography 
of an intrauterine gestational sec< 16mm without an embryo may be compatible with a 
viable pregnancy.
They  suggested  that  this  finding  was  associated  with  a  poor  outcome,  with 
miscarriage occurring in two thirds of patients.
Dukovski  A (2002) Studied about treatment with human chorinic gonadotropin 
(Pregnyl) of patients with vaginal bleed in the first trimester and found that the treatment 
with pregnyl is very good in patients with vaginal bleed in early pregnancy.
AlzarJL,  Ruiz  –  Perez  ML  (2000) studied  about  uteroplacental  circulation  in 
patients  with  first  –  trimester  threatened  abortion  using  Transitional  color  Doppler 
ultrasound measurement of peak systolic velocity and pulsatility of uterine arteries.
There was no apparent alteration in the early uteroplacental circulation in patients 
with threatened abortion with a living embryo, The use of transvaginal color Doppler is 
not useful for predicting pregnancy   outcome. 
Tongsong T, Srisomboon J, Wanapirak (1995) concluded that first trimester bleed 
with  visible  fetal  heart  appears  to  associate  significantly  with  higher  subsequent 
spontaneous abortion rate.
Neiger R. Wise C, Contag SA, Tumber MB, Canick JA (1993) studied about the first 
trimester bleed and pregnancy outcome in gravidas with normal and low folate levels 
and they concluded that in pregnancies complicated by first trimester vaginal bleeding, 
low folate levels do not appear to be associated with an increased risk of pregnancy loss 
and adverse outcome.
Sipil  P.  Hartikainen -  Sorri  AL, Oja H, Von Wendt L (1992) made a study on 
perinatal outcome of pregnancies complicated by vaginal bleeding. They concluded that 
bleeding was most frequent in women of more advanced age (>35 years) with previous 
miscarriages,  with  infertility  problems  or  using  an  IUCD  prior  to  the  pregnancy. 
Caesarean section  rate  and placental  complications  during the  third  trimester  and at 
delivery were more common among the bleeders than in the reference group.  The  Low 
Birth Weight rate was three fold among bleeders and the preterm birth rate was two fold. 
No association existed between bleeding and perinatal mortality.  So Bleeding duing the 
first trimester indicates a poor pregnancy outcome and  an increased risk of  low Birth 
weight and preterm birth and Congenital malformation.
Dickey  RP,  Olar  TT,  Curole  DN,  Taylor,  SN  (1992)  made  a  study  on 
the  relationship  of  first  trimester  subchorionic  bleed  detected  by  color 
Doppler  ultrasound  to  subchorionic  fluid,  clinical  bleeding  and  pregnancy 
outcome. They found that Embryonic deaths were increased only in patients 
with  large  amounts  of  subchorionic  fluid  observed  on  abdominal 
ultrasound.  Embryonic  deaths  occurred  equally  often  in  women  with  no 
fluid  and  in  those  with  subchorionic  fluid,  with  and  without  subchorionic 
bleeding.   Abortuses  were  karyotypically  abnormal  in  equal  proportion  of 
cases with subchorionic bleeding  ,  subchorionic fluid and no fluid.   These 
findings  indicate  that  subchorionic  fluid  and  subchorionic  bleed  are 
common findings in early pregnancy and are not associated with embryonic 
death unless they are accompanied by clinical bleeding.
Ruge  S.  Srensen  S.  Pedersen  JF,  Lange  A.P.  Bohn  H  (1991)  made  a 
study  on  the  role  of  Secretory  endometrial  protein  PP14  in  women  with 
early pregnancy bleeding.
They  concluded  that  no  difference  was  found  in  the  serum  level  of 
Secretory  Endometrial  protein  PP14  compared  to  that  in  normal 
pregnancies  but  women  with  Vaginal  bleeding  and  decreased  PP14  levels 
appeared to  have a 5 fold higher  risk of  preterm delivery than women with 
bleeding and normal PP14 levels.
Hill  LM,  Guzick  D.  Fries  J,  Hixson  J  (1991)  studied  about  the  fetal 
loss rate after  ultrasonically  documented cardiac activity between 6 and 14 
weeks of  menstrual  age  and reported that  the miscarriage rate  was  4.2% in 
patients  without  Vaginal  bleed   as  compared  to12.7%  in  patients  with 
vaginal bleeding.  First  trimester   bleed  was a significant covariate in the 
determination  of  the  spontaneous  miscarriage  rate  after  fetal  cardiac 
activity has been confirmed.
Takeda  S.  Baba  K.  Kojima  T.  Kinoshita  K.  Satoh  K  (1990)  after 
ultrasound monitoring of the placenta in patients with bleeding during first 
trimester concluded that subchorionic hematoma and marginal separation of 
placenta  may  be  important   causes  of  bleeding  during  pregnancy, 
monitoring  of  the  placenta  and  fetus  by  ultrasound  was  used  to  obtain 
precise  information in order  to manage patients  with bleeding.   It  might  be 
speculated  that  extrachorial  placenta  results  from  subchorionic  hematoma 
or its absorption.
Rosati  P, Exacoustos C, Masini L, Mancuso S (1989)  studied about the 
usefulness  and  limits  of  the  ultrasonic  examination  in  the  diagnosis  and 
prognosis  of  early  pregnancies  with  vaginal  bleeding  and  concluded  that 
there  are  no significant  differences  between normal  or  abnormal  ultrasonic 
examinations.   The  ultrasound  scanning  in  patients  with  early  pregnancy 
bleeding  is  able  to  differentiate  between  live  gestation   or  abortion  but 
cannot predict the future.
Bloch  C,  Altchek  A,  Levy  Ravetch  M  (1989)  made a  study  on  the 
significance of subchorionic hemorrhage by using sonography in pregnancy 
with  first  trimester  bleed  and  they  concluded  that  the  prognosis  of 
pregnancy  in  the  group  of  women with  bleed  and  sonographic  evidence  of 
subchorionic hemorrhage and fetal cardiac activity was 80% favourable.
Radikov  N  (1989)  found  the  relevance  of  pregnancy  specific  beta  - 
glycoprotein  in  the  serum  of  women  with  a  complicated  early  pregnancy 
and  concluded  that  the  examination  of  pregnancy  specific  beta  I 
glycoprotein  in  women  with  threatened  early  pregnancy  is  of  prognostic 
significance for the outcome of pregnancy.
Adelusi B, Dava OA (1980) studied on the prognosis of pregnancy after 
threatened  abortion  and  concluded  that  uterine  bleed  as  a  symptom  of 
abortion appears  to  be of  greater  risk if  this  occurs  in the second trimester 
of  pregnancy and the predictive value of  circulating progesterone  levels  in 
Threatened  abortion  is  significant.   It  is  probable  that  uterine  bleed  in  the 
second  trimester  especially  when  this  is  associated  with  low  circulating 
levels of progesterone may be  pathognomonic of imminent abortion.
    Jandial  V,  Towler  CM,  Home  CH  (1978)  studied  on  the  plasma 
pregnancy  specific  beta  I  -  glycoprotein  in  complications  of  early 
pregnancy  and  concluded  that  single  HPL  estimations  proved  to  be  less 
useful in evaluating the outcome of complications of early pregnancy.
MATERIALS AND METHOD
In  the  present  study,  cases  of  threatened  miscarriage  have  been 
examined  from  early  in  the  first  trimester  and  followed  up  prospectively 
until the end of pregnancy.
Pregnant  women  who  seek  hospital  assessment  for  Vaginal  bleed  less 
than  12  weeks  of  Gestation  are  the  subjects  for  study  with  a  view  to 
evaluate the outcome of pregnancy following close antenatal  and intranatal 
and postnatal supervision. 
This  prospective  cohort  study was  done  in  the  Dept  of  Obstetrics   and 
Gynecology,  Institute  of  social  obstetrics,  Govt.  Kasthurba  Gandhi 
Hospital, Triplicane, Chennai in the year 2008-2009.
The  cases  were  selected  from  the  inpatient  department.  Participants 
with  significant  vaginal  bleed  in  the  first  trimester  were  recruited.   In  one 
year  of  period  200  cases  were  selected  as  study  group.   After  informed 
consent, women were recruited into the study.
The  Control  group consisted  of  age  -  matched  women who booked  for 
antenatal  care  in  the  hospital  during  the  same  time  period.   They  were 
identified  consecutively  matched  for  maternal  age,  from  the  obstetric  - 
ultrasound database as having attended for routine first trimester screening. 
Control  cases were excluded if  they had attended the Early pregnancy Unit 
with threatened miscarriage in the first trimester or if they gave any history 
of first trimester bleeding.
The  sample  size  was  400,  200  pregnant  women  in  the  threatened 
miscarriage group and 200 controls.
All  women  in  the  study  group  were  followed  prospectively  from their 
first  appointment  until  delivery.   The  Characteristics  of  all  the  patients 
related  to  their  age,  gravidity,.   period  of  Gestation,  Ultrasonic  results, 
duration  of  Bleed,  duration  of  hospital  stay,  treatment  modalities  and 
outcome  were  determined  and  data  were  collected  through  self 
administered structured questionnaire.
Outcome data  were  obtained from the  hospital  notes  and confirmed by 
telephone follow up wherever necessary.
Potential confounding factors were identified and adjustment was made 
in  the  statistical  models.   The  potential  confounding  factors  included 
maternal age ,.   gravidity and previous recurrent abortion, previous preterm 
delivery,  previous  induced  abortion,  previous  term  delivery,  previous 
pregnancy  with  a  chromosomal  abnormality  previous  pregnancy  with  a 
genetic abnormality and use of assisted reproduction technology.
The sample population was limited to primigravida and second gravida 
to minimise the potential confounding effect of parity.
Women  presenting  with  complete  and  incomplete  Abortions  were 
excluded.   Women  presenting  with  missed  miscarriages  were  excluded. 
Women  opting  for  termination  and    Women  with  multiple  pregnancies 
were excluded from the study group.
Women  with  fetal  malformations   or  hydatidiform  Moles   were 
excluded.  Women  who  had  a  second  trimester  miscarriage  were  also 
excluded.   Women  with  Congenital  uterine  Anomaly,  large  leiomyomata 
distorting the uterine cavity  or  a  known thrombophilia  were excluded from 
the study group.
Women  seeking  hospital  assessment  for  vaginal  Bleed  <12  wks  of 
Gestation  were  included.   Those  women  should  not  be  on  any  drugs  for 
hematological  problems.   There  should be no history of  similar  complaints 
in previous pregnancy.
There should not be any known hematological disorders.
The  following  adverse  pregnancy   outcomes  among  the  two  groups 
were then compared.
PREGNANCY COMPLICATIONS
Antepartum hemorrhage
a) Abruptio Placenta (Premature 
Separation of a normally implanted Placenta)
b) Placenta Previa (Placenta 
completely  or  partially  covering  the  internal 
os)
Low Lying placenta (Placental 
edge  actually  does  not  reach  the  internal   os 
but  is in close  promixity to it)
Preeclampsia (Blood 
pressure  >  140/90  mm  Hg  on  atleast  two 
occasions  >  6  hours  apart  with  significant 
proteinuria)
Eclampsia
DELIVERY COMPLICATIONS
1) Induction of Labour
2) Instrumental delivery by forceps or Vaccuum
3) Malpresentation
4) Caesarean Delivery
5) Manual Removal of Placenta
6) Post Partum Hemorrhage
NEONATAL COMPLICATIONS
1) Preterm Delivery
2) Still Birth
3) Early Neonatal Death
4) Low Birth Weight
5) Apgar Score <7 at 5 Mts
6) Admission to NNU
For  all  these  patients,  a  detailed  clinical  study  was  undertaken 
including  investigations  according  to  the  proforma   given  later  on.   They 
were  given  the  required  treatment  in  antenatal  period  and  admitted  in  the 
hospital  as  and when necessary.   The outcome data were obtained from the 
hospital notes and confirmed by telephone follow up wherever necessary.
                RESULTS AND ANALYSIS
In this study 200 cases were taken into consideration which were collected from 
inpatient department of Govt. Kasturba Gandhi Hospital, Chennai.
Pregnant  Women  seeking  hospital  assessment  for  Vaginal  bleed  less  than  12 
weeks of Gestation are considered for Study.  Patients who are enrolled in the case study 
had no significant  past  Medical illness.   Patients are not on drugs for hematological 
problems and no history of similar complaints in previous pregnancy. Patients do not 
have known hematological disorders and had no evidence of congenital anomalies.
Pregnant women with Incomplete and complete abortion or missed miscarriages 
are excluded from the study. Women opting for termination and women with multiple 
pregnancies are excluded.  Women with fetal malformations or hydatidiform mole are 
excluded.  Women with second trimester miscarriages are also excluded from the study 
group.
Patients are divided according to the outcome measures selected.
1. Patients with pregnancy complications.
a) Patients with signs and symptoms of Preeclampsia
b) Patients with Eclampisa
c) Patients with signs and symptoms of Abruptioplacenta
d) Patients with placenta previa.
2. Patients with Delivery Complications
a) Patients with Caesarean Delivery
b) Patients who had manual Removal of Placenta done after delivery.
c) Patients who developed significant post  partum hemorrhage.
d) Patients who went in for preterm Labour
e) Patients who developed premature rupture of Membranes.
3. Patients with Neonatal Complications
a) Patients with babies  weight less than 2500 g
b) Patients with babies delivered less than 37 completed weeks of Gestation but after 
24 weeks.
c) Patients with babies who went in for Early Neonatal death.
d) Patients with babies delivered with an APGAR score less than 7 at 5 minutes and 
admission to the neonatal unit.
TABLE – I
Total number of cases and control subjects studied in the present study.
Frequency Percent Valid 
Percent
Cumulative 
Percent
Valid Case
Control
Total
200
200
400
50.0
50.0
100.0
50.0
50.00
100.0
50.0
100.0
Table – I shows the total number of cases and control subjects in the present study to be 
400 with cases being 200 and control  subjects  being 200 and their  valid percentage 
being 50% respectively.
TABLE – II
Group Statistics
Group N Mean Std 
Deviation
STDError 
Mean
AGE Case 200 23.37 3.20 .23
Control 200 24.22 3.95 .28
Table – III
TABLE – IV
Case Processing Summary
TABLE – IV
Independent Samples Test
13.930 .000 -2.379 398 .018 -.86 .36 -1.56 -.15
-2.379 381.486 .018 -.86 .36 -1.56 -.15
Equal variances
assumed
Equal variances
not assumed
AGE
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
Case Processing Summary
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
400 100.0% 0 .0% 400 100.0%
GROUP * TY_GRAV
GROUP * PRE
ABORTION
GROUP * PRE
ECLAMPSIA
GROUP * ECLAMPSIA
GROUP * PROM
GROUP * ABR
PLACENTA
GROUP * LLP
GROUP * Preg outcome
GROUP * MOD OF DEL
GROUP * MAN REMOVAL
GROUP * PPH
GROUP * B_WT
N Percent N Percent N Percent
Valid Missing Total
Cases
TABLE – V
Type of Gravida of Patients
Table – V shows the type of Gravida of the patients. If has been found that 159 patients 
(79.5%)  in  the  case  group and 150 patients  (75%) in  the  control  Group have  been 
Crosstab
159 41 200
79.5% 20.5% 100.0%
150 50 200
75.0% 25.0% 100.0%
309 91 400
77.3% 22.8% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Primi Multi
TY_GRAV
Total
Chi-Square Tests
1.152b 1 .283
.910 1 .340
1.154 1 .283
.340 .170
1.149 1 .284
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
45.50.
b. 
primigravida and it  has been 41 patients  (20.5%) in the case group and 50 patients 
(25.0%) in  the control  group have been Multigravida.   It  has been found that  large 
number of patients belong to Primigravid group in this study.  No significant difference 
in the incidence of type of Gravida [ P.340 ]         has been observed in this study.
TABLE –V I
The number of previous abortions.
Number of Previous abortions
Table VI shows the number of previous abortions in the study group.  If has been found 
that 22 patients (11.0%) in the study group and 24 patients (12%) in the control Group 
have history of previous abortions.   89% of patients in the case Group and 88% of 
patients  in  the  Control  Group  had  no  history  of  previous  abortion.   No  significant 
difference in the study group  [P.875].was noted regarding the incidence of previous 
abortions.
Crosstab
22 178 200
11.0% 89.0% 100.0%
24 176 200
12.0% 88.0% 100.0%
46 354 400
11.5% 88.5% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
PRE ABORTION
Total
Chi-Square Tests
.098b 1 .754
.025 1 .875
.098 1 .754
.876 .438
.098 1 .754
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
23.00.
b. 
TABLE – VII
Incidence of Preeclampsia
Table VII shows the incidence of preeclampsia  in the study group.  It has been 
found that 10 patients (5.0%) in the study group and 15 patients (7.5%) in the control 
group had signs and symptoms of preeclampsia in the antenatal period.  No Statistically 
significant difference was detected regarding the incidence of preeclampsia [P.409]   in 
this study.
Crosstab
10 190 200
5.0% 95.0% 100.0%
15 185 200
7.5% 92.5% 100.0%
25 375 400
6.3% 93.8% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
PRE ECLAMPSIA
Total
Chi-Square Tests
1.067b 1 .302
.683 1 .409
1.073 1 .300
.409 .205
1.064 1 .302
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
12.50.
b. 
TABLE VIII
Incidence of Eclampsia
Table VIII shows the incidence of Eclampsia in the study  group. It has been observed 
that 1 patient[.5%] in the case group and 3 patients[1.55%] in the control group had 
Eclampsia  in  the antenatal  period.   No statistically  significant  difference [P.615]was 
observed regarding the incidence of Eclampsia in this study.
TABLE – IX
Incidence of Abruptio Placenta
Crosstab
1 199 200
.5% 99.5% 100.0%
3 197 200
1.5% 98.5% 100.0%
4 396 400
1.0% 99.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
ECLAMPSIA
Total
Chi-Square Tests
1.010b 1 .315
.253 1 .615
1.057 1 .304
.623 .312
1.008 1 .315
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is
2.00.
b. 
Table IX shows the incidence of Abruptio Placenta in the study group.  It has 
been observed   12  patients (6.0%)  in the case group and 1 patient in the control Group 
( .5%)  has Abruptio placenta.  A statistically significant difference (P.005)was  noted 
between the study and Control Group in  this study.
TABLE – X
Incidence of PROM (Premature Rupture of Membranes)
Crosstab
12 188 200
6.0% 94.0% 100.0%
1 199 200
.5% 99.5% 100.0%
13 387 400
3.3% 96.8% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
ABR PLACENTA
Total
Chi-Square Tests
9.620b 1 .002
7.951 1 .005
11.284 1 .001
.003 .001
9.596 1 .002
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
6.50.
b. 
Crosstab
13 187 200
6.5% 93.5% 100.0%
2 198 200
1.0% 99.0% 100.0%
15 385 400
3.8% 96.3% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
PROM
Total
Table X shows the incidence of Premature Rupture of Membranes in the study group.  It 
has been observed 13  Patients ( 6.5%  )  in the  case group and2 Patients (1%    ) in the 
control  Group  had  PROM.   A  statistically  significant  difference  was  (p.008)noted 
between the study and control Group in the study.
TABLE XI
Incidence of Low lying placenta
Chi-Square Tests
8.381b 1 .004
6.926 1 .008
9.329 1 .002
.006 .003
8.360 1 .004
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
7.50.
b. 
Crosstab
6 194 200
3.0% 97.0% 100.0%
2 198 200
1.0% 99.0% 100.0%
8 392 400
2.0% 98.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
LLP
Total
Chi-Square Tests
2.041b 1 .153
1.148 1 .284
2.134 1 .144
.284 .142
2.036 1 .154
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is
4.00.
b. 
Table XI Shows the incidence of Low lying Placenta in the study group.  It has been 
observed 6 patients (3.0%) in the case group and 2 patients (1.0%) in the control Group 
had  Low  lying  placenta.  No  Statistically  significant  difference(p.284)  was  noted 
between the study and control Group in this study.
TABLE –XII
Pregnancy outcome in the study group
Crosstab
32 168 200
16.0% 84.0% 100.0%
18 182 200
9.0% 91.0% 100.0%
50 350 400
12.5% 87.5% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Preterm Term
Preg outcome
Total
Chi-Square Tests
4.480b 1 .034
3.863 1 .049
4.533 1 .033
.049 .024
4.469 1 .035
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
25.00.
b. 
Table XII shows the incidence of pregnancy outcome in the study group.  It has 
been found that 32 patients (16.0%) in the case group and 18 patients (9.0%) in the 
control Group had Preterm Delivery.  It has been observed that 168 patients (84.0%)  in 
the case group and 182 patients (91.0%) in the control group had Term Deliveries.  A 
statistically  difference  was  noted  between  the  study  and  Control  in  the  number  of 
preterm deliveries in the present study.
TABLE  - XIII
Mode of delivery in the study group
Table XIII compares the incidence of Mode of Delivery in the study group.  It 
has been observed that 72 patients 36% in the case group and 88 patients (44%) in the 
Crosstab
72 128 200
36.0% 64.0% 100.0%
88 112 200
44.0% 56.0% 100.0%
160 240 400
40.0% 60.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
LSCS Normal
MOD OF DEL
Total
Chi-Square Tests
2.667b 1 .102
2.344 1 .126
2.670 1 .102
.126 .063
2.660 1 .103
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
80.00.
b. 
Control group got delivered by Caesarean section and 128 patients (64.0%) in the case 
group and 112 patients (56%) in the control Group delivered by Labour Natural.  No 
Significant  difference(P.1260) in the incidence of type of delivery was noted in this 
study.
TABLE XIV
Incidence of Manual Removal of Placenta
Table XIV shows the incidence of Manual Removal of placenta in the study 
Group.  It has been found that 23 patients (11.5%) in the study Group and 15 patients 
(7.5%) in the  Control Group had manual removal of placenta done in the post partum 
period.  A Statistically significant difference(P.233) was not observed in the incidence of 
manual Removal of Placenta in this study.
TABLE XV
Crosstab
23 177 200
11.5% 88.5% 100.0%
15 185 200
7.5% 92.5% 100.0%
38 362 400
9.5% 90.5% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
MAN REMOVAL
Total
Chi-Square Tests
1.861b 1 .173
1.425 1 .233
1.874 1 .171
.232 .116
1.856 1 .173
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum xpected c unt is
19.00.
b. 
Incidence of Post partum Hemorrhage
Table XV shows the incidence of post partum Hemorrhage in the study group.  It 
has been observed that 11 patients (5.5%) in the study group and 7 patients (3.5%) in the 
control  group  had  significant  post  partum  hemorrhage.   A  Statistically  significant 
difference(P.469) was not  noted in  the incidence of  post  partum hemorrhage in  this 
study.
TABLE XVI
Incidence of Low Birth Weight
Crosstab
11 189 200
5.5% 94.5% 100.0%
7 193 200
3.5% 96.5% 100.0%
18 382 400
4.5% 95.5% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
Yes No
PPH
Total
Chi-Square Tests
.931b 1 .335
.524 1 .469
.938 1 .333
.470 .235
.928 1 .335
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
9.00.
b. 
Crosstab
36 164 200
18.0% 82.0% 100.0%
8 192 200
4.0% 96.0% 100.0%
44 356 400
11.0% 89.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Case
Control
GROUP
Total
LBW Normal
B_WT
Total
Table  XVI  Shows the  incidence  of  Low Birth  Weight  of  babies  in  the  study 
group.  It has been observed  that36 patients ( 18% ) in the study group and 8  patients 
( 4.0% ) in the control Group delivered babies with Low Birth Weight (<2500g).  A 
Statistically  significant  difference (P.0001 )was noted between the study and control 
group in this study.
      
complication Case Control odds ratio 95% CI p-value
LBW 18 4 5.3 2.3-12.7 0.0001
Manual removal 11.5 7.5 1.6 0.8-3.4 0.233
PROM 6.5 1 6.9 1.5-44.8 0.008
Abr-placenta 6 0.5 12.7 1.7-264.3 0.005
PPH 5.5 3.5 1.6 0.6-4.7 0.469
Preeclampsia 5 7.5 0.7 0.3-1.6 0.409
LLP 3 1 3.1 0.6-22.2 0.284
Eclampsia 0.5 1.5 0.3 0.01-3.58 0.615
Chi-Square Tests
20.020b 1 .000
18.616 1 .000
21.477 1 .000
.000 .000
19.970 1 .000
400
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is
22.00.
b. 
DISCUSSION
It is already known that First – Trimester Vaginal bleeding affects upto 25% of all 
pregnancies and reported to lead to spontaneous miscarriage in 50% of affected women. 
These data showed that threatened miscarriage is not only associated with miscarriage 
but also associated with adverse pregnancy outcome.
Results  from this  study  confirm findings  from other   authors  that  threatened 
abortion is associated with an increased risk of certain pregnancy related complications 
namely  placental  abruption,  preterm  labour,  delivery  of  Low  Birth  weight  babies, 
Premature Rupture of Membranes. 
Generally high incidence of abortion and complications in threatened miscarriage 
indicate the necessity of proper programming in care and cure and also educating high 
risk women.
A potential limitation of this study is that the severity of vaginal bleed was based 
on a subjective description by the patient.  However the ultimate assessment of vaginal 
bleeding is based on patient report.  Therefore we believe the results of this study can be 
applied to clinical practice.
Results of  this study support other evidence to indicate that in some patients first 
trimester  vaginal  bleeding may indicate  underlying placental  dysfunction which may 
manifest in later pregnancy by a variety of adverse outcomes that have also been related 
to placental dysfunction.
It has been found in this study that majority of cases belonged to the age group of 
20-30 years and perhaps the reason  is that majority of delivery also occur in this age 
group as  Mckeon (1954)  concluded  that the best time of women to have first baby is 
between the age of 20-30 years.
Table V shows that out of 200 cases with threatened miscarriage 79.5% of cases 
were primigravida and 20.5% of cases were multigravida.  But a statistically significant 
difference between the case and control in this study was not noted.  Basama FM (2004) 
found  that  previous  miscarriage  has  no  influence  in  the  outcome  of  Threatened 
miscarriage. Table VI shows that out of 200 cases with threatened miscarriage 11.0% of 
cases had history of previous abortion and 12% of Control group had history of previous 
abortion.   So  no  significant  association(P.875)  is  found  between  vaginal  bleed  and 
history of previous abortions.
In one study by John vidaver / Robert H (2003) an increased risk of preeclampsia 
preterm delivery/ placental abruption and caesarean delivery was observed for patients 
who reported light bleeding. For patients who reported heavy vaginal bleeding during 
first  trimester  they  observed  increased  risks  of  IUGR,  Preterm 
delivery,PPROM,Placental Abruption  and caesarean delivery. In our study increased 
risk of preterm delivery, PROM, Abruptio placenta and LBW was observed in patients 
with first trimester bleed.
In  1993,  Verma  et  al reported  that  pregnancy  induced  hypertension  was 
significantly more common in subjects with threatened abortion and a viable pregnancy 
compared with subjects without vaginal bleeding (6% Vs. 4.7% respectively; p<0.05). 
Another study did not find an association between first trimester vaginal bleeding and 
gestational hypertension but did find that patients with light bleeding were statistically 
more likely to have preeclampsia.  This association carried a low OR of <2.0 Likely we 
don’t find any significant association between vaginal bleed and preeclampsia. Table 
VII Shows out of 200 cases with threatened miscarriage 5% of cases had signs and 
symptoms of preeclampsia as compared with 7.5% in the control group.
Table  X  shows  that  out  of  200  patients  6.5%  of  patients  with  threatened 
miscarriage had premature rupture  of  membranes as  compared to  1% in the control 
group.  So our findings corroborate other studies that suggested an associated between 
threatened abortion and PROM.  Although the cause is unclear it is hypothesized that 
disruption of  the chorionic  – amniotic  plane by adjacent  hemorrhage may make the 
membrane more susceptible to rupture.  Alternatively the prolonged presence of blood 
may act as a nidus for intrauterine infection.
Table IX shows that out of 200 cases with first trimester bleed 6.0% of cases had 
abruptio  placenta  as  compared  with  0.5%  of  Control.   A  statistically  significant 
association between vaginal bleeding and Abruptio placenta was found.
Das et al. Dhaliwal LK reported an increased risk for a lowlying placenta among 
women  with  threatened  miscarriage  but  found  no  difference  in  placental  location 
compared with control subjects by 36 weeks of Gestation. Out data shows that in Table 
XI that out of 200 cases with first trimester bleed only 3% had low lying placenta.  No 
significant  association  could  be  demonstrated  between  threatened  miscarriage  and 
placenta praevia.
Preterm delivery before 37 weeks gestation occurs in 7-11% of pregnancies but is 
responsible for 85% of deaths of normally formed infants.  Despite significant advances 
in perinatal medicine the incidence of preterm delivery has remained unchanged.  The 
only potential risk factor found to be associated significantly with the risk of preterm 
delivery  in  women  with  a  threatened  miscarriage  was  unexplained  antepartum 
hemorrhage rather than other factors such as premature rupture of membranes.   The 
association of vaginal bleed with preterm deliveries has also been noted by others.
Batzofin of al and William et al reported that patients with threatened miscarriage 
had double the risk of preterm delivery compared with patients without bleeding.  The 
study of Williams et al was limited to first trimester bleeding.  Batzofin et al included 
patients with bleeding upto 20 weeks.  Strobino and Pantel silverman failed to show as 
association between preterm delivery with light vaginal bleeding in the first trimester of 
pregnancy.  In our study statistically significant association between study and control 
subjects was noted (P.0.049) Table XII shows that out of 200 cases with threatened 
miscarriage 32 cases had preterm delivery and that is around 16.0% as compared with 
9.0% in the control group.
Currently there is not information in the literature regarding threatened abortion 
and caesarean delivery.  Table XIII shows that out of 200 cases with first trimester bleed 
36.0% were  delivered  by  caesarean  section  as  compared  with  44.0% in  the  control 
group.  No significant association could be demonstrated between patients with vaginal 
bleed in first trimester and caesarean delivery in our study.  But F Davari – Tanha et al 
reported  statistical association between threatened abortion and the risk for caesarean 
delivery.
Hertz JB.  Heisenberg (1985) reported that Retention of placenta was associated 
with threatened miscarriage and the rate of Manual Removal was 14% They postulated 
that  adhesive scarring between the uterine wall  and the placenta at  the site of bleed 
might be responsible for the increased incidence of retention of placenta in women with 
threatened miscarriage.  Table XIV Shows that out of 200 patients with first trimester 
bleed 11.5% of cases had Manual Removal of placenta done as compared to 7.5% of 
control  subjects.   No statiscally  significant  association between the case and control 
could be demonstrated in our study.
Table XV shows out of 200 patients with first trimester bleed 5.5.% of patients 
had  post  partum  Hemorrhage  as  compared  to  3.5%  of  control.   No  significant 
association could be found between case and control in postpartum hemorrhage. 
Haddow  et  al reported  an  increased  risk  for  Low  birth  weight  (<2500g)  in 
pregnancies that were complicated by vaginal bleeding.  Table XVII shows that out of 
200 patients 18% of patients with threatened miscarriage delivered babies with birth 
weight of <2500 g as compared with 4% of patients in control.  A statistically significant 
association between patients with first trimester bleed and low birth weight could be 
demonstrated in our study.
SUMMARY AND CONCLUSION
A prospective study of outcome of pregnancy in 200 cases of patients with first 
trimester bleeding was undertaken.
The  patients  were  followed  up  prospectively  from  examination  in  the  first 
trimester until the end of pregnancy.  The Pregnancy and Delivery complications like 
antepartum  Hemorrhage  (Placenta  previa  and  Abruptio  placenta)  Eclampsia, 
Preeclampsia,  Premature  Rupture  of  Membranes,  Low  Lying  Placenta,  Pregnancy 
outcome, Mode of Delivery, Manual Removal of Placenta,  Post Partum Hemorrhage 
and Low Birth Weight were determined and the outcome data obtained.
In out study in 5% of cases had preeclampsia, 0.5% of cases had Eclampsia 6.5% 
of cases had premature Rupture of  Membranes,  6% of cases had Abruptio placenta, 
3.0% of cases had Low Lying Placenta, 16% of cases had preterm deliveries,  36% of 
cases were delivered by caesarean sections and 11.5% of cases had Manual Removal of 
placenta done, 5.5% of cases had significant post partum Hemorrhage and 18% of cases 
delivered babies of Low Birth Wt
There is no specific treatment for threatened abortion.  Bed rest although often 
advocated  is  not  effective.  No  consistent  evidence  shows  that  bed  rest  can  affect 
pregnancy outcome in threatened abortion.  However it is not harmful and may provide 
the patient with some emotional comfort.
In general most do not administer progesterone or sedatives.  In most instances of 
threatened abortions that ultimately result in complete abortion, the embryo is already 
dead; thus the administration of progesterone drugs is ineffective and only prolongs the 
natural  course  of  abortion.   However  progesterone  (Vaginal  administration)  may  be 
indicated in unique circumstances including viable pregnancies achieved with advanced 
reproductive  technology  of  patients   with  a  history  of  an  inadequate  luteal  phase. 
Studies  have  shown  that  although  progesterone  administration  may  not  necessarily 
change the outcome of threatened abortion, it may help reduce the severity of symptoms 
such as pain from cramping and uterine contractions.  Empirically there is no role of 
hormone  therapy  but  undiagnosed  deficiency  can  be  corrected  by  17  hydroxyl 
progesterone corporate or Dydrogesterone.  Aspirin may be given to improve placental 
circulation.
The use of uterine muscle relaxants or tocolytics is not supported by adequate 
evidence. 
Folic acid may be used to prevent neural tube defect and abruptio placenta.
Appropriate counseling for all patients can be instituted.  A continuing support 
and sympathetic attitude and follow up care are important to patients.  This includes a 
tactful  explanation about  the pathological  process and favorable  prognosis  when the 
pregnancy is viable.
It  is  observed that early and comprehensive prenatal  care can decrease risk of 
threatened abortion to some extent.  So Increased antenatal surveillance might identify 
women within this group who are at increased risk.  Knowledge of this increased risk 
may also facilitate decision making regarding management,  mode, place and time of 
delivery which will inevitably improve pregnancy outcome.
Although from our study it is reassuring that the majority of women with first 
trimester bleeding have pregnancy outcomes comparable to those without such bleeding 
it is evident that they face a higher relative risk of some adverse obstetric and neonatal 
outcomes.   This  information  is  helpful  in  terms  of  counseling  women  and  alerting 
clinicians to early signs of these complications.
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